Hank F. Kung
Affiliations: | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Pharmacology, Organic Chemistry, Pharmaceutical ChemistryGoogle:
"Hank Kung"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Zha Z, Ploessl K, Choi SR, et al. (2020) Preclinical evaluation of [F]D3FSP, deuterated AV-45, for imaging of β-amyloid in the brain. Nuclear Medicine and Biology |
Xu X, Zhu H, Liu F, et al. (2020) Dynamic PET/CT imaging of F-(2S, 4R)4-fluoroglutamine in healthy volunteers and oncological patients. European Journal of Nuclear Medicine and Molecular Imaging |
Liu S, Wu R, Sun Y, et al. (2020) Design, synthesis and evaluation of a novel glutamine derivative (2S,4R)-2-amino-4-cyano-4-[18F]fluorobutanoic acid New Journal of Chemistry. 44: 9109-9117 |
Zhang L, Zhang A, Yao X, et al. (2019) An improved preparation of [ F]AV-45 by simplified solid-phase extraction purification. Journal of Labelled Compounds & Radiopharmaceuticals |
Zhao R, Zha Z, Yao X, et al. (2019) VMAT2 imaging agent, D6-[F]FP-(+)-DTBZ: Improved radiosynthesis, purification by solid-phase extraction and characterization. Nuclear Medicine and Biology. 72: 26-35 |
Yao X, Zha Z, Zhao R, et al. (2019) Optimization of solid-phase extraction (SPE) in the preparation of [F]D3FSP: A new PET imaging agent for mapping Aβ plaques. Nuclear Medicine and Biology. 71: 54-64 |
Sun M, Xiao H, Hong H, et al. (2019) Rapid screening of nine unradiolabeled candidate compounds as PET brain imaging agents using cassette-wave microdosing and LC-MS/MS. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1121: 28-38 |
Huang Y, Liu S, Wu R, et al. (2019) Synthesis and preliminary evaluation of a novel glutamine derivative: (2S,4S)4-[F]FEBGln. Bioorganic & Medicinal Chemistry Letters |
Zhang Y, Zhang L, Yang J, et al. (2019) Initial experience in synthesis of (2S,4R)-4-[18F]fluoroglutamine for clinical application. Journal of Labelled Compounds & Radiopharmaceuticals |
Zhu H, Liu F, Zhang Y, et al. (2019) (2S,4R)-4-[F]Fluoroglutamine as a PET Indicator for Bone Marrow Metabolism Dysfunctional: from Animal Experiments to Clinical Application. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging |